**Recent legislative action and political calendar dynamics explain the strong trader consensus favoring "No."** The One Big Beautiful Bill Act, enacted in 2025, already restored full R&D expensing and delivered other corporate relief valued in the tens of billions, while extending key 2017 Tax Cuts and Jobs Act provisions. Treasury guidance now under development further eases corporate alternative minimum tax interactions with those deductions, providing implementation-level benefits rather than new statutory reductions. With the 2026 midterms less than three weeks away and voter attention centered on affordability, living costs, and foreign policy rather than additional tax legislation, prospects for further corporate rate cuts or major new relief before 2027 remain limited. Fiscal pressures and the narrow window before year-end also constrain near-term action. Traders therefore price a high probability that no additional corporate tax cuts will occur in the remaining period.